Seoul, South Korea

Jee Soo Son

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 6.6

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Jee Soo Son - Revolutionizing Pathogen Treatment

Introduction:

Jee Soo Son, a prolific inventor based in Seoul, South Korea, has made significant strides in the field of pathogen treatment with an impressive portfolio of 20 patents to his name. His groundbreaking innovations in utilizing bacteriophages to combat infections have garnered widespread acclaim and attention in the scientific community.

Latest Patents:

Son's latest patents showcase his pioneering work in developing compositions and methods for inhibiting the proliferation of pathogenic bacteria. One patent involves the use of Podoviridae bacteriophage (Esc-COP-30) to effectively lyse pathogenic bacteria, offering a promising approach for preventing and treating infections. Another patent features Myoviridae bacteriophage Esc-COP-18, which demonstrates similar efficacy in combating pathogenic bacteria. These inventions highlight Son's commitment to advancing medical treatments through cutting-edge technology.

Career Highlights:

Currently affiliated with Intron Biotechnology, Inc., a renowned biotech company at the forefront of innovative research, Jee Soo Son continues to push the boundaries of medical science. His expertise and dedication have solidified his reputation as a key figure in the field of biopharmaceuticals, contributing significantly to advancements in pathogen treatment.

Collaborations:

Son's collaborative efforts with esteemed colleagues such as Seong Jun Yoon and Sang Hyeon Kang have been instrumental in expanding the scope of his research. Together, they have synergized their skills and knowledge to develop novel solutions for combating infectious diseases, further underscoring Son's collaborative spirit and leadership in the scientific community.

Conclusion:

Inventor Jee Soo Son's remarkable contributions to the field of pathogen treatment stand as a testament to his innovative prowess and unwavering commitment to improving global healthcare. With a diverse portfolio of patents and a penchant for groundbreaking discoveries, Son continues to inspire and drive positive change in the realm of biopharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…